Nomograms for Predicting Survival of Patients With Newly Diagnosed Glioblastoma: Prognostic Factor Analysis of EORTC and NCIC Trial 26981-22981/Ce.3
The Lancet Oncology - United Kingdom
doi 10.1016/s1470-2045(07)70384-4
Full Text
Open PDFAbstract
Available in full text
Categories
Date
January 1, 2008
Authors
Publisher
Elsevier BV